Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (Q167209)

From geokb
Revision as of 13:49, 24 May 2024 by Sky (talk | contribs) (‎Created a new Item: Added new OpenAlex topic claimed by USGS staff from API)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
This cluster of papers focuses on the genomic aberrations, treatment strategies, and prognostic factors associated with chronic lymphocytic leukemia (CLL)
  • Chronic Lymphocytic Leukemia
  • Genomic Aberrations
  • BTK Inhibitors
  • Rituximab
  • Ibrutinib
  • Prognostic Factors
  • TP53 Mutation
  • Waldenström Macroglobulinemia
  • Immunoglobulin Mutation
  • Therapeutic Targets
Language Label Description Also known as
English
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia
This cluster of papers focuses on the genomic aberrations, treatment strategies, and prognostic factors associated with chronic lymphocytic leukemia (CLL)
  • Chronic Lymphocytic Leukemia
  • Genomic Aberrations
  • BTK Inhibitors
  • Rituximab
  • Ibrutinib
  • Prognostic Factors
  • TP53 Mutation
  • Waldenström Macroglobulinemia
  • Immunoglobulin Mutation
  • Therapeutic Targets

Statements